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The genetic properties of seven cold-adapted variants of influenza virus A were 
compared with those of nine Lfluorouracil (5-FU)-induced ts mutants. The 5-FU mu- 
tants had previously been placed into seven complementation-recombination groups; 
five of the seven cold-adapted variants also had the ts phenotype, and all five were shown 
to share the group 1 lesion. Three of the cold variants also had additional ts lesions. 
INTRODUCTION 
Recent attempts to control influenza A 
virus epidemic and pandemic disease by 
live virus vaccination have involved the 
production of updated vaccine strains by 
transfer of gene(s) conferring attenuation 
from attenuated donors to the current epi- 
demic wild-type (wt) subtype (Beare and 
Hall, 1971; Beare and McCahon, 1972; Fen- 
ner, 1972; Maassab et al., 1972; McCahon 
and Schild, 1972; Murphy et al., 1973,1974; 
Beare et al., 1975). Three types of donor 
viruses have been suggested: (i) tempera- 
ture-sensitive (6s) mutants (often derived 
by mutagenesis) which are restricted in 
their ability to produce plaques at 38 or 
39”; (ii) cold-adapted variants which can 
replicate equally well at 25 and 33”, while 
the wt parent can replicate only at 33”; 
and (iii) viruses attenuated by passage 
in eggs or tissue culture. Vaccine strains 
prepared by each of these methods ap- 
pear to be attenuated both in man and 
I Address reprint requests to Dr. Spring. 
z Supported in part by the office of the U.S. Army 
Medical Research and Development Command, De- 
partment of the Army, under Research Contract 
DADA 17-73-C-3060. 
animals when compared with the homolo- 
gous wild-type parent (Maassab, 1967, 
1969, 1970; Boudreault et al., 1968; Maas- 
sab et al., 1969, 1972; Mills et al., 1969; 
Smorodincev, 1969; Beare et al., 1971; 
Beare and Hall, 1971; Mills and Chanock, 
1971; Beare and McCahon, 1972; McCahon 
and Schild, 1972; Murphy et al., 1972,1973, 
1974,1976; Edwards et al., 1972; Izuchi and 
Mizutani, 1973; Mizutani and Izuchi, 1973; 
Davenport et al., 1975; Beare et al., 1975; 
Richman et al., 1975; Spring et al., 1975b). 
However, ts mutants and cold variants 
have the potential advantage that they 
possess in vitro markers which are associ- 
ated with attenuation. These markers can 
be assessed in tissue culture before the 
viruses are evaluated in man. 
A set of nine temperature-sensitive mu- 
tants of influenza A derived by mutagene- 
sis with 5-fluorouracil (5-FU) has recently 
been placed into seven complementation 
groups (Spring et al., 1975b) on the basis of 
a complementation-recombination assay 
carried out directly on the tissue culture 
monolayer. Previous studies (Maassab, 
1967; Medvedeva et al., 1969; Maassab, 
1969, 1970; Maassab et al., 1969) have sug- 
gested that cold-adapted variants of influ- 
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enza virus are temperature sensitive in Growth and Assay of Infectious Virus 
chick kidney tissue culture. We therefore 
sought to use the 5 FU mutants as genetic 
Suspensions of ts mutants or cold var- 
probes to ascertain whether the two sets of 
iants were prepared by allantoic inocula- 
viruses shared ts lesions. 
tion of lo-day-old embryonated eggs and 
harvest of the allantoic fluid after 48-72 hr 
MATERIALS AND METHODS 
of incubation at 33”. Embryonated eggs 
were obtained from either Truslow Farms 
Viruses 
(Chestertown, Maryland) or SPAFAS Inc. 
(Storrs, Connecticut). 
(i) ts Mutants. The production and Plaque assays were performed using 
characterization of the ts mutants and ts rhesus monkey kidney (RMK) monolayers 
recombinants used as prototypes for each grown on plastic petri dishes. An agar 
of the complementation groups have been overlay consisting of 0.9% agarose, me- 
detailed previously (Murphy et al., 1975; dium L-15, and antibiotics was used (Mills 
Richman et al., 1975; Spring et al., and Chanock, 1971; Murphy et al., 1974). 
1975a,b). In studies performed at restrictive temper- 
(ii) Cold-adapted variants. Two meth- atures (37, 38, and 39”), the tissue culture 
ods were used in the production of cold plates were sealed in steel boxes which 
variants: (i) The A/AA/Marten/43 (HONl), were placed in a constant-temperature cir- 
A/FM/l/47 (HlNl), and A/AA/6160 (H2N2) culating water bath (maximum variation, 
strains were adapted by multiple succes- 0.05”). Tissue cultures were purchased 
sive passages in chick kidney tissue cul- from Flow Laboratories, Inc. (Rockville, 
ture at progressively lower temperatures Maryland). 
(intervals of 3”) (Maassab, 1967). (ii) The Studies comparing the efficiency of plat- 
A/AA/2165 (H2N2), A/AA/2167 (H2N2), Al ing of virus strains and isolates at 25 or 33” 
Aichil2168 (H3N2), and A/AA/l/70 (H3N2) were carried out in chick kidney (CK) cul- 
strains were cold-adapted by a second tures. The preparation of these cells from 
method: The parental strain was passaged l- to 4-day-old chicks and the assay proce- 
three times in chick kidney tissue culture dure have been previously described 
at 25”; plaques were then selected at 25” in (Maassab, 1967, 1969). The cells in such 
this same cell line (Maassab, 1970). The cultures are predominantly epitheloid, but 
properties of these viruses are summarized fibroblast-like cells are also in evidence. 
in Table 1. 
Complementation-Recombination Assay 
Antigenic Analysis The technique for the detection of com- 
The subtype of the hemagglutinin anti- plementation-recombination on the assay 
gen was determined by hemagglutination 
plate has been described in detail previ- 
inhibition (HI) using AIAAIMartonl43 
ously (Mills and Chanock, 1971; Spring et 
(HONl), A/Great Lakes138911965 (H2N2), al., 1975b) and is summarized in Results. 
and AIHKIX-31168 (H3N2) as reference an- 
tigens. Reference antisera were produced 
RESULTS 
in chickens to the AlAAlMartonl43 Antigenic Analysis 
(HONl), A2/Taiwanlll64 (H2N2), and Evaluation by HI and neuraminidase in- 
AlAichil2168 (H3N2) strains. hibition (NI) indicated that each of the 
Procedures similar to the WHO test pro- 
tocol for neuraminidase specificity were 
cold variants had the surface antigens of 
the wild-type parent (Table 1). 
employed (Aymard-Henry et al., 1973). 
Antiserum to the Nl antigen was prepared Characterization of Cold-Adapted Var- 
in chickens using the H equi 1 Nl (Bel) iants with Respect to Efficiency of 
recombinant as antigen; antiserum to the Plaque Formation (EOP) 
N2 antigen was prepared using the H 
equi 1 N2 (Aichi) recombinant as antigen. 
Replicate sets of CK monolayers were 
inoculated with serial dilutions of cold var- 
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iants or parental wt strains and incubated 
for 3-5 days at 25 or 33”. The titer in 
plaque-forming units (PFU) per milliliter 
at each temperature was then calculated. 
Table 2 presents the log reduction of the 
titer at 25” with respect to the titer at 33”. 
These data indicate that each of the cold 
variants produced plaques with high effi- 
ciency at 25”, whereas the wt parent of 
each variant did not induce plaques at this 
temperature. 
Replicate sets of RMK monolayers were 
inoculated with serial dilutions of the cold 
variants or parental wt strains and incu- 
bated for 3 days at 37, 38, or 39” or for 5 
days at 33”; the titer in PFU per milliliter 
at each temperature was then calculated. 
Table 2 presents the log reduction of the 
TABLE 1 
ts LESIONS IN COLD VARIANTS 
Cold variant Method of derivation” Shared lesions Shutoff tem- 
(complemen- perature’ 
tation group)” 
A/AA/Marten/43-HONl Stepwise - >39 
A/FM/i/47-HlNl Stepwise - B39 
A/AA/6/60-H2N2 Stepwise 1 37 
A/AA/2/65-H2N2 Plaque selection 1 38 
A/AA/2/67-H2N2 Plaque selection 1, 3, 5 37 
A/Aichi/2/68-H3N2 Plaque selection i, 6 38 
A/AA/i/70-H3N2 Plaque selection 1, 3, 6 38 










b Determined by complementation-recombination assay on RMK monolayers using 5-FU-Hong Kong& 
mutants and recombinants as prototypes. 
” Taken as temperature at which there is a loo-fold or greater loss in plaquing efficiency on RMK 
monolayers. 
” Determination described in text. 
TABLE 2 
PLAQUINC EFFICIENCY OF COLD-ADAPTED VARIANTS AND PARENTAL STRAINS AT PERMISSIVE AND RESTRICTIVE 
TEMPERATURES 
Virus Log reduction Log reduction of plaque titer at indicated Shutoff tem- 
in plaque titer restrictive temperature from titer ob- peraturein 
at 25” from ti- served at permissive temperature (33”) in RMK cells” 
ter observed RMK tissue culture (“C) 
at 33” in CK 









































































fl Defined as a loo-fold or greater reduction in plaquing efficiency on RMK monolayers. 
b Not done. 
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titer at each of the three restrictive tem- 
peratures with respect to the titer at the 
permissive temperature (33”). The shutoff 
temperature of each mutant was arbitrar- 
ily chosen as the lowest temperature at 
which there was a loo-fold or greater de- 
crease in titer. The values shown in Table 
2 represent the average log reduction of 
two or three tests on different lots of RMK 
cells. None of the parental viruses was 
restricted significantly in plaquing eff- 
ciency at 39”. Only the A/AA/2165 strain 
produced fewer plaques at 39”, and, in this 
instance, the restriction was only lo-fold. 
In contrast, five of the seven cold variants 
were temperature sensitive and suffi- 
ciently restricted in plaque formation at 39 
to permit genetic analysis with the proto- 
type 5-FU ts mutants. Two of the cold varl 
iants were not sufficiently temperature 
sensitive to be analyzed by complementa- 
tion-recombination with the prototype 5- 
FU ts mutants. 
Genetic Characterization of Cold-Adapted 
Variants 
The five ts cold-adapted variants were 
analyzed by the plate complementation- 
recombination technique to determine in 
which complementation group or groups 
they belonged. The nine 5-FU mutants 
previously assigned to seven complemen- 
tation groups were used as prototype 
strains for this purpose (Spring et al., 
1975b). 
Pairs of mutants were mixed and incu- 
bated at 4” for 18 hr. Serial dilutions of the 
mixtures were made and inoculated onto 
RMK monolayer cultures. The cultures 
were then incubated at 39”. Replicate mon- 
olayers were also inoculated with each in- 
dividual mutant and incubated at 33” or 
39”. The resulting titer at 33” was used to 
estimate the input multiplicity. Few if any 
plaques developed following incubation of 
singly infected cultures at 39”; in those 
instances in which a mutant produced a 
small number of plaques at 39”, the appro- 
priate adjustment was made in calculating 
the number of plaques expected following 
dual infection with other mutants at re- 
strictive temperature. In each test, one or 
more wild-type strains were assayed at 33” 
and 39”, and the titers for each virus were 
always approximately equal at the two 
temperatures. 
When dually infected cell monolayers 
were incubated at 39”, the number of 
plaques which developed varied from none 
for certain pairs of mutants to a quantity 
which equalled or exceeded the number 
expected assuming a Poisson distribution 
of dually infected cells and an efficiency of 
plaque formation by such cells of 100%. 
Mutant pairs such as A/AA/Marten/6/60- 
cold variant and ts 463 for which the ratio 
of observed to expected plaques was 
greater than 1 (Table 3) were assumed to 
possess ts lesions in different cistrons of 
their genome. Thus, each of the viruses 
could supply the biochemical function 
which was defective in the other, resulting 
in complementation followed by reassort- 
ment of the viral genomes. Mutant pairs 
which failed to produce plaques at the re- 
strictive temperature, e.g., Rl and A/AA/ 
Martonl6/60-cold variant, were assumed to 
have ts lesions in the same cistron of their 
genome. The results summarized in Table 
3 represent at least four tests for each mu- 
tant pair. The data suggested that all five 
ts cold-adapted viruses shared the ts lesion 
represented by complementation group 1. 
In addition, the cold variants derived from 
the 1967, 1968, and 1970 strains appeared 
to possess additional lesions. The findings 
are summarized in Tables 1 and 3. Three 
pairs of viruses exhibited variable interac- 
tion (Table 3). The values presented are 
consistent with the results of 70% of multi- 
ple assays (lo-15 assays per pair). Varia- 
bility of genetic interaction between cer- 
tain pairs of mutants has been observed 
previously in the complementation-recom- 
bination assay, and several hypotheses 
have been proposed to explain it (Spring et 
al., 1975a). 
DISCUSSION 
The data presented in Tables 1 and 3 
suggest that the five cold variants which 
are temperature sensitive share the group 
1 lesion. The concurrent acquisition of a ts 
mutation during selection for cold adapta- 
tion has also been observed with mutants 
of poliovirus, Japanese B encephalitis vi- 
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TABLE 3 
PRODUCTION OF PLAQUES AT RESTRICTIVE TEMPERATURE FOLLOWING DUAL INFECTION WITH PUTATIVE SINGLE- 
Cold-adapted var- 
iant 
Ii1 3:4 5 6 7 463 
315 422 454 464 
A/AA/6/60-H2N2 <O.OOl 50 250 2 6 20 20 100 
A/AA/2/65-H2N2 <O.OOl 4 20 5 33 3 1 20 
A/AA/2/67-H2N2 <0.003 1 6 co.01 <O.Ol 1 1 20 
A/Aichi/2/68-H3N2 <0.002 1’ 2 10 2 <O.OOl <O.Ol 10 
A/AA/i/70-H3N2 <O.Ol 5 10 1 1 co.01 co.002 10 
a Values are based on Poisson distribution, assuming that it is necessary for a cell to receive 1 plaque- 
forming unit of each virus to produce a plaque at 39”. The formula (1 - ema I(1 - ema)(number of cells) is used 
where mA and mB are the input multiplicities of the infecting viruses. Values are representative of a mini- 
mum of four tests between each pair. Each test was carried out on a separate lot of RMK cells, and calcula- 
tions of input virus were based on the titer at 33” of each mutant on that lot of cells. 
b Spring et al. (1975b). 
r Variable interaction was exhibited in these crosses. From 10 to 15 tests were carried out for these pairs, 
and the values presented are consistent with 70% of the tests. 
LESION ts MUTANTS AND COLD VARIANTS” 
Complementation group and prototype 5-FU ts viruses* 
rus, and measles virus (Dubes and 
Chapin, 1956; Dubes and Wenner, 1957; 
Hammon et al., 1963; Hozinski et al., 
1966). Since the five cold variants of influ- 
enza were independently derived, it ap- 
pears that the process of low-temperature 
selection may preferentially select viruses 
with ts lesions on the complementation 
group 1 portion of the genome. Sponta- 
neous or mutagen-induced mutants of in- 
fluenza A (Hirst, 1973; Sugiura et al., 1972, 
1975) or mutagen-induced mutants of fowl 
plaque virus (Markushin and Ghendon, 
1973; Scholtissek and Bowles, 1975) often 
appear to occur preferentially in one or two 
complementation groups. Preliminary 
findings suggest that the group 1 lesion 
may be associated with a defect in cRNA 
synthesis and probably with the transcrip- 
tase complex.3 It is likely that the first 
obstacle to replication of a negative-strand 
virus would be the synthesis of cRNA 
which functions as mRNA and thus starts 
the synthesis of viral products. If the group 
1 function is an enzyme, it is possible that 
certain mutations result in altered en- 
:] These data are based on complementation-re- 
combination studies (Spring and Chanock, manu- 
script in preparation) between the 5-Fu Hong Kong 
ts prototypes and the WSN ts mutants which have 
been studied biochemically by Sugiura et al. (1975) 
and by Krug et al. (1975). 
zyme conformation and, consequently, a 
shift in the temperature optimum such 
that the enzyme activity would be both 
cold adapted and ts, whereas other altera- 
tions in the amino acid sequence may in- 
duce only cold adaptation. 
However, these findings do not preclude 
more than one cistron being involved in 
the cold adaptation property: (i) There are 
two cold variants, A/AA/Mar-ton/43 
(HONl) and A/FM/l/47 (HlNl), which are 
cold-adapted and not ts. (ii). Additional ts 
lesions are also present in three cold var- 
iants, A/AA/2157 (H2N21, A/Aichi/2/68 
(H3N2), and A/AA/l/70 (H3N2). It is note- 
worthy that the group 5 and 6 lesions in 
these viruses also appear to involve cRNA 
and vRNA, respectively.” Studies are cur- 
rently in progress to segregate by recombi- 
nation the groups 1, 3, 5, and 6 ts lesions 
occurring in multilesioned cold variants 
and to ascertain whether single lesion ts 
segregants retain the cold-adaptation 
property. 
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